Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Candida albicans exposures, sex specificity and cognitive deficits in schizophrenia and bipolar disorder.

Severance EG, Gressitt KL, Stallings CR, Katsafanas E, Schweinfurth LA, Savage CL, Adamos MB, Sweeney KM, Origoni AE, Khushalani S, Leweke FM, Dickerson FB, Yolken RH.

NPJ Schizophr. 2016 May 4;2:16018. doi: 10.1038/npjschz.2016.18. eCollection 2016.

2.

Probiotic normalization of Candida albicans in schizophrenia: A randomized, placebo-controlled, longitudinal pilot study.

Severance EG, Gressitt KL, Stallings CR, Katsafanas E, Schweinfurth LA, Savage CLG, Adamos MB, Sweeney KM, Origoni AE, Khushalani S, Dickerson FB, Yolken RH.

Brain Behav Immun. 2017 May;62:41-45. doi: 10.1016/j.bbi.2016.11.019. Epub 2016 Nov 18.

3.

Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia.

Severance EG, Gressitt KL, Stallings CR, Origoni AE, Khushalani S, Leweke FM, Dickerson FB, Yolken RH.

Schizophr Res. 2013 Aug;148(1-3):130-7. doi: 10.1016/j.schres.2013.05.018. Epub 2013 Jun 6.

4.

Cognitive functioning in schizophrenia and bipolar disorder: comparison of performance on the Repeatable Battery for the Assessment of Neuropsychological Status.

Dickerson F, Boronow JJ, Stallings C, Origoni AE, Cole SK, Yolken RH.

Psychiatry Res. 2004 Nov 30;129(1):45-53.

PMID:
15572184
5.

Elevated C-reactive protein and cognitive deficits in individuals with bipolar disorder.

Dickerson F, Stallings C, Origoni A, Vaughan C, Khushalani S, Yolken R.

J Affect Disord. 2013 Sep 5;150(2):456-9. doi: 10.1016/j.jad.2013.04.039. Epub 2013 May 17.

PMID:
23684514
6.

Antibodies to Toxoplasma gondii and cognitive functioning in schizophrenia, bipolar disorder, and nonpsychiatric controls.

Dickerson F, Stallings C, Origoni A, Katsafanas E, Schweinfurth L, Savage C, Khushalani S, Yolken R.

J Nerv Ment Dis. 2014 Aug;202(8):589-93. doi: 10.1097/NMD.0000000000000166.

PMID:
25010110
7.
9.

[Cognitive deficits in first episode psychosis patients and people at risk for psychosis: from diagnosis to treatment].

Lecardeur L, Meunier-Cussac S, Dollfus S.

Encephale. 2013 May;39 Suppl 1:S64-71. doi: 10.1016/j.encep.2012.10.011. Epub 2013 Mar 23. Review. French.

PMID:
23528322
10.

Additive effects of elevated C-reactive protein and exposure to Herpes Simplex Virus type 1 on cognitive impairment in individuals with schizophrenia.

Dickerson F, Stallings C, Origoni A, Vaughan C, Khushalani S, Yolken R.

Schizophr Res. 2012 Jan;134(1):83-8. doi: 10.1016/j.schres.2011.10.003. Epub 2011 Nov 1.

PMID:
22048011
11.

Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results.

Dittmann S, Seemüller F, Schwarz MJ, Kleindienst N, Stampfer R, Zach J, Born C, Bernhard B, Fast K, Grunze H, Engel RR, Severus E.

Bipolar Disord. 2007 Feb-Mar;9(1-2):63-70.

PMID:
17391351
12.

Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study.

Hill SK, Reilly JL, Keefe RS, Gold JM, Bishop JR, Gershon ES, Tamminga CA, Pearlson GD, Keshavan MS, Sweeney JA.

Am J Psychiatry. 2013 Nov;170(11):1275-84. doi: 10.1176/appi.ajp.2013.12101298.

13.

Association between cognitive functioning, exposure to Herpes Simplex Virus type 1, and the COMT Val158Met genetic polymorphism in adults without a psychiatric disorder.

Dickerson F, Stallings C, Sullens A, Origoni A, Leister F, Krivogorsky B, Yolken R.

Brain Behav Immun. 2008 Oct;22(7):1103-7. doi: 10.1016/j.bbi.2008.04.156. Epub 2008 Jun 20.

PMID:
18571372
14.
15.

[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].

Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B.

Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9. French.

PMID:
19081451
16.

Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects.

Altshuler LL, Ventura J, van Gorp WG, Green MF, Theberge DC, Mintz J.

Biol Psychiatry. 2004 Oct 15;56(8):560-9.

PMID:
15476685
17.

Gastrointestinal inflammation and associated immune activation in schizophrenia.

Severance EG, Alaedini A, Yang S, Halling M, Gressitt KL, Stallings CR, Origoni AE, Vaughan C, Khushalani S, Leweke FM, Dickerson FB, Yolken RH.

Schizophr Res. 2012 Jun;138(1):48-53. doi: 10.1016/j.schres.2012.02.025. Epub 2012 Mar 24.

18.

Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder.

Dickerson FB, Boronow JJ, Stallings C, Origoni AE, Cole S, Krivogorsky B, Yolken RH.

Biol Psychiatry. 2004 Mar 15;55(6):588-93.

PMID:
15013827
19.

Clinical and neuropsychological correlates of insight in schizophrenia and bipolar I disorder: does diagnosis matter?

Varga M, Magnusson A, Flekkøy K, David AS, Opjordsmoen S.

Compr Psychiatry. 2007 Nov-Dec;48(6):583-91. Epub 2007 Aug 21.

PMID:
17954145
20.

Inflammatory markers are associated with general cognitive abilities in schizophrenia and bipolar disorder patients and healthy controls.

Hope S, Hoseth E, Dieset I, Mørch RH, Aas M, Aukrust P, Djurovic S, Melle I, Ueland T, Agartz I, Ueland T, Westlye LT, Andreassen OA.

Schizophr Res. 2015 Jul;165(2-3):188-94. doi: 10.1016/j.schres.2015.04.004. Epub 2015 May 5.

PMID:
25956633

Supplemental Content

Support Center